Usana Health Sciences (FRA:USJ) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:USJ Usana Health Sciences Inc FRA:USJ
68 GF Score
Price €19.50
GF Value €36.47
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Usana Health Sciences Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:USJ
68GF Score
Usana Health Sciences Inc FRA:USJ
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Usana Health Sciences (FRA:USJ) Overvalued in 2026?

Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued. The current stock price of €19.50 is trading 46.5% below its estimated GF Value™ of €36.47. GuruFocus considers Usana Health Sciences to be Possible Value Trap.

Key valuation signals for FRA:USJ:

  • Dividends Received:
  • GF Value™: €36.47 vs. price of €19.50 (46.5% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the FRA:USJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Usana Health Sciences Business Description

Other Exchanges USNA:USA
Address 3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
68GF Score

Get the complete analysis for FRA:USJ

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.50
Price
€36.47
GF Value